QQ客服 官方微博 反馈留言

	Higher Anti-angiogenesis Activity, Better Cellular Uptake and Longer Half-life of a Novel Glyco-modified Endostatin by Polysulfated Heparin
	Sun, Feng; Shaikh, Abdul Sami; Wang, Juan; Gao, Hui; Yang, Zhifang; Wang, Zhendong; Li, Yan; Wang, Fengshan; Tan, Haining
刊名	CURRENT PHARMACEUTICAL BIOTECHNOLOGY
	2018
卷号	19期号:12页码:996-1004
关键词	Polysulfated heparin endostatin cellular uptake anti-angiogenesis activity pharmacokinetics anti-angiogenesis activity
DOI	10.2174/1389201020666181120164753
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4583669
专题	山东大学
作者单位	Shandong Univ, Natl Glycoengn Res Ctr, Sch Pharmaceut Sci, Jinan 250
推荐引用方式 GB/T 7714	Sun, Feng,Shaikh, Abdul Sami,Wang, Juan,et al. Higher Anti-angiogenesis Activity, Better Cellular Uptake and Longer Half-life of a Novel Glyco-modified Endostatin by Polysulfated Heparin[J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY,2018,19(12):996-1004.
APA	Sun, Feng.,Shaikh, Abdul Sami.,Wang, Juan.,Gao, Hui.,Yang, Zhifang.,...&Tan, Haining.(2018).Higher Anti-angiogenesis Activity, Better Cellular Uptake and Longer Half-life of a Novel Glyco-modified Endostatin by Polysulfated Heparin.CURRENT PHARMACEUTICAL BIOTECHNOLOGY,19(12),996-1004.
MLA	Sun, Feng,et al."Higher Anti-angiogenesis Activity, Better Cellular Uptake and Longer Half-life of a Novel Glyco-modified Endostatin by Polysulfated Heparin".CURRENT PHARMACEUTICAL BIOTECHNOLOGY 19.12(2018):996-1004.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。